• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Nov27
Distribution Plan(CST)

Cash dividend 0.127 CNY

Nov22
Distribution Plan(CST)

Cash dividend 0.127 CNY

Nov21
Distribution Plan(CST)

Cash dividend 0.127 CNY

View More

Event Tracking

Dec19
Hengrui Pharmaceutical's Subsidiary Obtains Clinical Trial Approval for Leuprorelin Acetate Microspheres Injection
12:01
Hengrui Medicine Subsidiary Receives Clinical Trial Approval Notice for SHR-2906 Injection
08:57
Dec18
WuXi Biologics Shareholders Reduce Holdings, Stake Drops to 16.97%
09:47
WuXi Lux Holding Subsidiary Acquires Fund Investment and Transfers Shares
09:23
Dec17
JPMorgan Increases Its Stake in WuXi Biologics by 872,123 Shares
11:20
Dec15
WuXi AppTec Completes Sale of Kendrion and ZS Medicine Shares to Hillhouse
14:27